The Istanbul Mehmet Akif Ersoy Hospital provides care for all medical indications, with specialization in cardiology and pulmonology. The hospital’s catchment area has a population of 4.5 M. It is the only training and research hospital for cardiovascular surgery on the European side of Turkey. It is also the only public hospital in Turkey with an international health accreditation awarded by the Joint Commission International.
IMAEH will have more than 600 beds in 2018, including an intensive care unit with 174 beds. With PRS IMAEH will be able to identify and recruit patients also in an emergency setting. IMAEH adds more than 2 million medical records and 260,000 patient lives to PRS.
Joining the PRS platform means that IMAEH will become more visible to international sponsors seeking sites for clinical trials. Patients at IMAEH will now have access to a wider range of treatment options and physicians at IMAEH will be able to offer a better standard of care.
PRS performs medical data analytics on EHR-based patient data from its network of partner hospitals for the purposes of patient search and identification for clinical trials, data generation for real-world evidence and market access activities. Clinerion guarantees patient privacy through the exclusive use of anonymized patient data, while still enabling the re-identification of candidates for clinical trials by authorized hospital staff via the use of its patent-protected “Anonymous Identification” (ANID) technology.
“We are very happy to join Clinerion and PRS,” said Dr. Mehmet Ertürk, Chief Physician of IMAEH. “Patients who are candidates for clinical trials can be analyzed accurately and effectively with PRS, whilst ensuring the very important protection of personal data, patient safety, reliability of operation and supervision. PRS allows a huge efficiency improvement in running clinical studies, by finding and identifying the target numbers of patients for enrolment in trials in a very short time and reliably. This will contribute to the increase in the number of clinical trials in our country.”
“IMAEH is a great addition to the PRS platform,” said Barış Erdoğan, Clinerion’s Head of EEMEA. “IMAEH is the only public hospital with a Phase-I Center in Turkey. Together, we will have the chance to facilitate phase II-IV trials by enhancing standard operating procedures and leveraging state-of-the-art technology to increase speed, efficiency and productivity.”
